NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Assets | ₹163 Cr | ₹173 Cr | ₹125 Cr | ₹81 Cr | ₹86 Cr |
What is the latest Total Current Assets ratio of NGL FINECHEM ?
Year | Total Current Assets |
---|---|
Mar2023 | ₹163 Cr |
Mar2022 | ₹173 Cr |
Mar2021 | ₹125 Cr |
Mar2020 | ₹81 Cr |
Mar2019 | ₹86 Cr |
How is Total Current Assets of NGL FINECHEM Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹163 Cr | -6.25 | |
Mar2022 | ₹173 Cr | 39.32 | |
Mar2021 | ₹125 Cr | 54.00 | |
Mar2020 | ₹81 Cr | -6.42 | |
Mar2019 | ₹86 Cr | - |
Compare Total Current Assets of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,552.2 Cr | -5.2% | 18.1% | 76.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -5.2% |
18.1% |
76.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses